Actively Recruiting
Aerobic Fitness or Muscle Mass Training to Improve Colorectal Cancer Outcome
Led by Radboud University Medical Center · Updated on 2023-11-18
228
Participants Needed
13
Research Sites
300 weeks
Total Duration
On this page
Sponsors
R
Radboud University Medical Center
Lead Sponsor
U
UMC Utrecht
Collaborating Sponsor
AI-Summary
What this Trial Is About
Evidence from randomized controlled trials shows that exercise during cancer treatment benefits physical fitness, fatigue and quality of life. Since the effect of exercise on clinical outcome is currently unknown, exercise is not included as integral part of standard cancer care. Moreover, evidence regarding the optimal exercise prescription in terms of type and dose is lacking. To maintain quality of life in patients receiving palliative treatment with chemotherapy, toxicity-induced modifications in the prescribed chemotherapy dose are common. Such modifications - occurring in 40% of patients with metastatic colorectal cancer - may reduce benefit of treatment. The investigators hypothesize that exercise prevents chemotherapy dose modifications by reducing toxicity and enhancing psychological strength. Additionally, based on studies in rodents and preliminary data in patients with cancer, the researchers hypothesize that exercise has beneficial effects on the functionality of the natural killer cells, which play an important role in the innate immune defense against cancer. Both, fewer dose modifications and improved immune function may improve progression-free survival. This study is a three-armed trial comparing resistance exercise, aerobic interval exercise and usual care in patients with metastatic colorectal cancer to select the optimal exercise prescription for preventing chemotherapy dose modifications. The trial will use a Bayesian adaptive multi-arm multi-stage design with several interim analyses after which an ineffective study arm can be dropped early. This novel design makes the trial more efficient and reduces patients' exposure to suboptimal study arms. Evidence regarding the exercise effects on i) clinical outcome, ii) the optimal exercise prescription, and iii) the underlying mechanisms, elucidates the potential of exercise to boost benefit from chemotherapy treatment. This evidence provides leads to improve progression-free survival and quality of life of patients suffering from one of the leading causes of cancer death worldwide.
CONDITIONS
Official Title
Aerobic Fitness or Muscle Mass Training to Improve Colorectal Cancer Outcome
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with metastatic colorectal cancer requiring palliative chemotherapy
- Scheduled for first-line doublet or triplet chemotherapy according to national guidelines
- Able and willing to provide written informed consent
You will not qualify if you...
- Life expectancy less than 6 months
- Unable to perform basic daily activities such as walking or biking
- Presence of cognitive disorders or severe emotional instability (e.g., schizophrenia, Alzheimer’s, alcohol addiction)
- Other disabling conditions affecting exercise ability (e.g., severe heart failure, severe COPD, orthopedic or neurological disorders)
- Insufficient mastery of the Dutch language
- Serious cardiovascular or cardiopulmonary conditions risking exercise safety
- Already participating in structured vigorous aerobic or resistance exercise two or more times per week similar to the intervention
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 13 locations
1
Jeroen Bosch Ziekenhuis
's-Hertogenbosch, Netherlands, 5223 GZ
Actively Recruiting
2
Flevoziekenhuis
Almere Stad, Netherlands, 1315 RA
Actively Recruiting
3
Meander Medisch Centrum
Amersfoort, Netherlands, 3813TZ
Actively Recruiting
4
Ziekenhuis Amstelland
Amstelveen, Netherlands, 1186AM
Actively Recruiting
5
Amsterdam UMC
Amsterdam, Netherlands, 1007MB
Actively Recruiting
6
Netherlands Cancer Institute
Amsterdam, Netherlands
Actively Recruiting
7
Rijnstate Ziekenhuis
Arnhem, Netherlands, 6815 AD
Actively Recruiting
8
Ziekenhuis Amphia
Breda, Netherlands, 4818CK
Actively Recruiting
9
Catharina Ziekenhuis
Eindhoven, Netherlands, 5623 EJ
Actively Recruiting
10
Spaarne Gasthuis
Hoofddorp, Netherlands, 2134TM
Actively Recruiting
11
Radboudumc
Nijmegen, Netherlands, 6525GA
Actively Recruiting
12
Canisius Wilhelmina Ziekenhuis
Nijmegen, Netherlands, 6532SZ
Actively Recruiting
13
UMCU
Utrecht, Netherlands, 3508GA
Actively Recruiting
Research Team
L
Laurien M Buffart, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here